American Health Packaging is recalling 13,229 cartons of Aspirin and Extended-release Dipyridamole Capsules (25 mg/200 mg), a prescription medication used to reduce the risk of stroke. The recall was initiated because routine stability testing found an unknown impurity that exceeded safety specifications. This recall affects unit-dose cartons containing 20 capsules each, which were distributed nationwide across the United States. Consumers should contact their healthcare provider or pharmacist regarding this recall and for guidance on their treatment.
The presence of an unknown impurity means the medication does not meet the required quality and safety standards, which could potentially lead to unexpected side effects or reduced effectiveness of the treatment.
Refund and guidance via pharmacy and healthcare provider.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.